Spinraza

Biogen touts stronger-than-expected rollout for Spinraza
BioPharma Dive
Wed, 04/26/17 - 10:58 am
Biogen
Spinraza
drug launches
SMA
spinal muscular atrophy
​Biogen shares jump as launch of new drug beats expectations
Bizjournals.com
Tue, 04/25/17 - 11:29 am
Biogen
Spinraza
earnings
Facing a payer backlash over sticker shock, Biogen fields positive data on Spinraza for children 2-12
Endpoints
Mon, 04/24/17 - 10:09 am
Biogen
Spinraza
payers
Did Biogen Inc. Shoot Itself in the Foot?
Motley Fool
Tue, 02/21/17 - 11:11 am
Biogen
drug pricing
Spinraza
SMA
spinal muscular atrophy
Another US insurer places limits on Spinraza coverage
BioPharma Dive
Fri, 02/10/17 - 12:08 pm
Biogen
Spinraza
spinal muscular atrophy
insurers
Humana
Biogen's latest drug may be costly, but new data suggests it saves lives
Bizjournals.com
Sat, 01/14/17 - 03:37 pm
Biogen
Spinraza
SMA
spinal muscular atrophy
Is Spinraza worth $750K? Biogen says yes, spelling out reduced death risk
Endpoints
Fri, 01/13/17 - 09:41 am
Biogen
Spinraza
SMA
spinal muscular atrophy
Why Spinraza Is The Only Exciting Thing About Ionis Pharmaceuticals
Yahoo/Benzinga
Sat, 01/7/17 - 12:55 pm
Ionis Pharmaceuticals
Spinraza
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
biotech
M&A
drug launches
Gilead Sciences
Incyte
Spinraza
Biogen
Ionis Pharmaceuticals
Amgen
Regeneron
Sanofi
New drug price controversy looms as Biogen stuns payers with Spinraza’s $750K sticker — analyst
Endpoints
Thu, 12/29/16 - 12:24 pm
Biogen
Spinraza
drug pricing
spinal muscular atrophy
The FDA's Christmas Breakthrough
Forbes
Tue, 12/27/16 - 10:10 am
FDA
Biogen
spinal muscular atrophy
Spinraza
Nusinersen

Pages